LCGRX
Price
$24.80
Change
-$0.10 (-0.40%)
Updated
Aug 15 closing price
Net Assets
2.12B
VEXPX
Price
$116.37
Change
-$0.16 (-0.14%)
Updated
Aug 15 closing price
Net Assets
19.88B
Interact to see
Advertisement

LCGRX vs VEXPX

Header iconLCGRX vs VEXPX Comparison
Open Charts LCGRX vs VEXPXBanner chart's image
Loomis Sayles Small Cap Growth Retail
Price$24.80
Change-$0.10 (-0.40%)
VolumeN/A
Net Assets2.12B
Vanguard Explorer I
Price$116.37
Change-$0.16 (-0.14%)
VolumeN/A
Net Assets19.88B
LCGRX vs VEXPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LCGRX vs. VEXPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCGRX is a Hold and VEXPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 19.9B vs. LCGRX (2.12B). VEXPX pays higher dividends than LCGRX: VEXPX (0.40) vs LCGRX (0.00). LCGRX was incepted earlier than VEXPX: LCGRX (29 years) vs VEXPX (58 years). LCGRX (1.19) is less costly to investors than VEXPX (0.44). LCGRX is a more actively managed with annual turnover of: 39.00 vs. VEXPX (35.00). LCGRX has a lower initial minimum investment than VEXPX: LCGRX (2500) vs VEXPX (3000). LCGRX annual gain was more profitable for investors over the last year : 0.85 vs. VEXPX (-1.90). VEXPX return over 5 years is better than : 5.07 vs. LCGRX (-4.14).
LCGRXVEXPXLCGRX / VEXPX
Total Expense Ratio1.190.44270%
Annual Report Gross Expense Ratio1.190.44270%
Fund Existence29 years58 years-
Gain YTD-0.4021.235-33%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.12B19.9B11%
Annual Yield % from dividends0.000.40-
Returns for 1 year0.85-1.90-45%
Returns for 3 years6.445.40119%
Returns for 5 years-4.145.07-82%
Returns for 10 years5.3119.9227%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIJYX33.120.29
+0.88%
Fidelity Advisor Biotechnology Z
SIEPX14.500.05
+0.35%
Saratoga International Equity I
PNECX10.96N/A
N/A
Virtus NFJ Dividend Value C
PRPHX66.32-0.14
-0.21%
Permanent Portfolio Permanent C
TMIFX11.23-0.06
-0.53%
Transamerica Mid Cap Growth R4